Increased histone deacetylase 6 expression serves as a favorable prognostic factor for diffuse large B-cell lymphoma.

about

Increased histone deacetylase 6 expression serves as a favorable prognostic factor for diffuse large B-cell lymphoma.

Item

http://www.wikidata.org/entity/Q45227214

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Increased histone deacetylase ...... diffuse large B-cell lymphoma.

@en

Increased histone deacetylase ...... diffuse large B-cell lymphoma.

@nl

type

Item

label

Increased histone deacetylase ...... diffuse large B-cell lymphoma.

@en

Increased histone deacetylase ...... diffuse large B-cell lymphoma.

@nl

prefLabel

Increased histone deacetylase ...... diffuse large B-cell lymphoma.

@en

Increased histone deacetylase ...... diffuse large B-cell lymphoma.

@nl

P1476

Increased histone deacetylase ...... diffuse large B-cell lymphoma.

@en

P2093

Chen-Yi Wang

http://www.w3.org/2001/XMLSchema#string

Hai-Yan Lin

http://www.w3.org/2001/XMLSchema#string

He Huang

http://www.w3.org/2001/XMLSchema#string

Li-Meng Cai

http://www.w3.org/2001/XMLSchema#string

Ni Sun

http://www.w3.org/2001/XMLSchema#string

Rong-Xin Yao

http://www.w3.org/2001/XMLSchema#string

Wen-Jian Guo

http://www.w3.org/2001/XMLSchema#string

Xiao-Hai Sun

http://www.w3.org/2001/XMLSchema#string

Xiao-Ji Lin

http://www.w3.org/2001/XMLSchema#string

Zi-Jun Qian

http://www.w3.org/2001/XMLSchema#string

P2860

Three proteins define a class of human histone deacetylases related to yeast Hda1p

Acetylation of histones and transcription-related factors

Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)

Histone deacetylase 6 plays a role as a distinct regulator of diverse cellular processes

Histone deacetylases and cancer

New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project

Identification of a new family of higher eukaryotic histone deacetylases. Coordinate expression of differentiation-dependent chromatin modifiers

Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma.

Deacetylase inhibitors: an advance in myeloma therapy?

Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin's lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms

P304

5129-5136

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S142974

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29123411

http://www.w3.org/2001/XMLSchema#string

P932

5661447

http://www.w3.org/2001/XMLSchema#string